Transcranial Photobiomodulation For The Management Of Depression: Current Perspectives

Código QR

Transcranial Photobiomodulation For The Management Of Depression: Current Perspectives

Paula Askalsky,1 Dan V Iosifescu1,2 1Department of Psychiatry, NYU Langone School of Medicine, New York, NY, USA; 2Clinical Research Division, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USACorrespondence: Dan V IosifescuDepartment of Psychiatry, NYU School of Medicine, One Park...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Askalsky P, Iosifescu DV
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	low-level light therapy photobiomodulation near infrared radiation major depressive disorder depression Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/498f5347d9f5474c8589fc4b89d79bbb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Neural Activation via Acupuncture in Patients With Major Depressive Disorder: A Functional Near-Infrared Spectroscopy Study
por: Tingyu Zhang, et al.
Publicado: (2021)

Photobiomodulation using high- or low-level laser irradiations in patients with lumbar disc degenerative changes: disappointing outcomes and remarks
por: Taradaj J, et al.
Publicado: (2018)

Integration of the Cortical Haemodynamic Response Measured by Functional Near-Infrared Spectroscopy and Amino Acid Analysis to Aid in the Diagnosis of Major Depressive Disorder
por: Samantha K. Ong, et al.
Publicado: (2021)

Evaluation of cognitive impairment in patients with major depressive disorder in remission
por: Mustafa Ali, et al.
Publicado: (2021)

Mindfulness-based cognitive therapy in patients with depression: current perspectives
por: MacKenzie MB, et al.
Publicado: (2018)

Task and Non-task Brain Activation Differences for Assessment of Depression and Anxiety by fNIRS
por: Dan Wen, et al.
Publicado: (2021)

Predictors of Major Depressive Disorder in Older People
por: Susana Sousa, et al.
Publicado: (2021)

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy
por: Zafiris J. Daskalakis, et al.
Publicado: (2021)

Validity of the Shahin Mixed Depression Scale: A Self-Rated Instrument Designed to Measure the Non-DSM Mixed Features in Depression
por: Shahin I, et al.
Publicado: (2020)

La terapia cognitiva en el tratamiento de la depresión mayor
por: Figueroa,Gustavo
Publicado: (2002)

Pioglitazone could induce remission in major depression: a meta-analysis
por: Colle R, et al.
Publicado: (2016)

Prefrontal Lobe and Posterior Cingulate Cortex Activations in Patients with Major Depressive Disorder by Using Standardized Weighted Low-Resolution Electromagnetic Tomography
por: I-Mei Lin, et al.
Publicado: (2021)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Wei Zheng, et al.
Publicado: (2021)

Potential Genetic Overlap Between Insomnia and Sleep Symptoms in Major Depressive Disorder: A Polygenic Risk Score Analysis
por: Lindsay M. Melhuish Beaupre, et al.
Publicado: (2021)

Taiwanese Depression Questionnaire and AD8 Questionnaire for Screening Late-Life Depression in Communities
por: Wei YC, et al.
Publicado: (2021)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita T, et al.
Publicado: (2016)

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang Y, et al.
Publicado: (2021)

MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
por: Miguel A. Ortega, et al.
Publicado: (2021)

Management of Treatment-Resistant Depression: Challenges and Strategies
por: Voineskos D, et al.
Publicado: (2020)

Comparing the Self- and External Assessment Versions of the HCL-33 as Screening Instruments for Bipolar Disorder in Older Depressed Patients
por: Xinqiao Zhang, et al.
Publicado: (2021)

Near-infrared spectroscopy as a promising tool in stroke: Current applications and future perspectives
por: Jinyan Sun, et al.
Publicado: (2021)

Clinical Response of Major Depressive Disorder Patients With Suicidal Ideation to Individual Target-Transcranial Magnetic Stimulation
por: Nailong Tang, et al.
Publicado: (2021)

Depression research and treatment

Preliminary Study on Changes of Sleep EEG Power and Plasma Melatonin in Male Patients With Major Depressive Disorder After 8 Weeks Treatment
por: Xue-Qin Wang, et al.
Publicado: (2021)

Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
por: Muste JC, et al.
Publicado: (2021)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich L, et al.
Publicado: (2018)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020)

Cognitive impairment in depression: recent advances and novel treatments
por: Perini G, et al.
Publicado: (2019)

Victimization In Childhood Affects Depression In Adulthood Via Neuroticism: A Path Analysis Study
por: Tachi S, et al.
Publicado: (2019)

Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
por: Sharareh Parami, et al.
Publicado: (2021)

Childhood Emotional Neglect Is Associated With Low Social Support in Chinese Patients With Major Depressive Disorder
por: Xuemei Qin, et al.
Publicado: (2021)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020)

Biomarkers for depression: recent insights, current challenges and future prospects
por: Strawbridge R, et al.
Publicado: (2017)

Identification of Gene Co-Expression Modules and Core Genes Related to Immune Disorders in Major Depression Disorder
por: Zhang L, et al.
Publicado: (2021)

Mind your state: Insights into antidepressant nonadherence
por: De Wet Wolmarans, et al.
Publicado: (2016)

Atypical depression: current perspectives
por: Łojko D, et al.
Publicado: (2017)

Prevalence of Major Depressive Disorder and Correlates of Thoughts of Death, Suicidal Behaviour, and Death by Suicide in the Geriatric Population—A General Review of Literature
por: Gloria Obuobi-Donkor, et al.
Publicado: (2021)

Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy
por: Wu B, et al.
Publicado: (2017)

Assessment of current clinical practices for major depression in Japan using a web-based questionnaire
por: Hori H, et al.
Publicado: (2019)

CHRONIC DEPRESSIVE DISORDERS
por: O. V. Petrunko
Publicado: (2017)